Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PhITT: Phentermine for Adolescents With Obesity
NCT07282340Phase 2Recruiting
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in childhood obesity comparing Phentermine 16 mg Group with Placebo Group (2 arms). Primary endpoint: Percent Change in BMI from Baseline at 52 weeks. Started Jun 2026; status: recruiting.
02
Drugs
phentermine
03
Conditions
childhood obesity
Beyond the preview
Go deeper on NCT07282340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07282340.